Novartis to shutter NC-based Sandoz plant ahead of spinoff
As Sandoz is ready to spin out from Novartis, the parent company is shuttering an oral solid dosage plant in Wilson, North Carolina.
The plant, which makes tablets and capsules for Canada and the US, employs about 246 people who have already been alerted to the closure, a Novartis spokesperson told several media outlets. But most of the employees are likely to be let go, unless there is a “late sale of the site” to a buyer interested in retaining staff, a spokesperson said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.